Sana Biotechnology Inc (SANA) — Financial Flexibility Index
Sana Biotechnology Inc (SANA) has a Financial Flexibility Index of -0.12x as of December 2025. Free cash flow of $-31.77 Million (operating CF $-32.64 Million minus capex $873.00K) represents 0% of total liabilities ($256.01 Million). Also explore Sana Biotechnology Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sana Biotechnology Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Sana Biotechnology Inc across 8 annual periods. Check SANA strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Sana Biotechnology Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Sana Biotechnology Inc. For the full company profile including market capitalisation, see SANA company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.56x | $-142.89 Million | $-143.83 Million | $256.01 Million | ▲ +26.3% |
| 2024 | -0.76x | $-189.72 Million | $-223.15 Million | $250.52 Million | ▲ +9.9% |
| 2023 | -0.84x | $-233.55 Million | $-253.58 Million | $277.79 Million | ▼ -1.0% |
| 2022 | -0.83x | $-269.17 Million | $-290.05 Million | $323.40 Million | ▼ -50.9% |
| 2021 | -0.55x | $-221.19 Million | $-251.05 Million | $400.90 Million | ▼ -456.8% |
| 2020 | -0.10x | $-114.11 Million | $-137.98 Million | $1.15 Billion | ▲ +6.8% |
| 2019 | -0.11x | $-59.32 Million | $-85.50 Million | $557.73 Million | ▲ +61.2% |
| 2018 | -0.27x | $-13.04 Million | $-13.49 Million | $47.52 Million | — |